PADI3 and breast carcinoma: Also, the use of specific internal peptide standards resulted in lower LLOQs as the cutoff for signal decay was improved by the presence of the standards’ corresponding transitions; this was particularly obvious for the measurement of PADI3 in the breast cancer samples.